Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam
May 10, 2024 16:02 ET
|
Cassava Sciences, Inc.
$126.3 Million In Total Gross Proceeds from Warrant Distribution.Over 1,900 Patients with Alzheimer’s Disease Are Randomized in Phase 3 Trials of Simufilam.Over 735 Patients Have Completed a Phase 3...
Senvest Capital Inc. annonce ses résultats pour le trimestre terminé le 31 mars 2024
May 10, 2024 16:01 ET
|
Senvest Capital Inc.
MONTRĖAL, 10 mai 2024 (GLOBE NEWSWIRE) -- Senvest Capital Inc. a annoncé aujourd’hui un résultat net attribuable aux actionnaires ordinaires de 52,3 M$ ou 21,17 $ par action pour les trois mois...
Senvest Capital Inc. Reports Results for the First Quarter Ended March 31, 2024
May 10, 2024 16:01 ET
|
Senvest Capital Inc.
MONTREAL, May 10, 2024 (GLOBE NEWSWIRE) -- Senvest Capital Inc. today reported net income attributable to common shareholders of $52.3 million or $21.17 per share for the three months ended March...
Table Trac, Inc. Reports 2024 First Quarter Earnings
May 10, 2024 15:24 ET
|
Table Trac, Inc.
MINNETONKA, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- Table Trac, Inc. (OTCQX: TBTC), a developer and provider of casino information and management systems that automate and monitor the operations of...
United-Guardian Reports Increased First Quarter Sales & Earnings
May 10, 2024 15:00 ET
|
United-Guardian, Inc.
HAUPPAUGE, N.Y., May 10, 2024 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the first quarter of 2024. First quarter sales increased from $2,570,324...
Merus gibt Finanzergebnisse für das erste Quartal 2024 bekannt und informiert über den aktuellen Geschäftsverlauf
May 10, 2024 12:36 ET
|
Merus N.V.
Petosemtamab in Kombination mit Pembrolizumab bei 1L (Erstlinientherapie) HNSCC – erste vorläufige klinische Daten auf der ASCO-Jahrestagung 2024; Vorbereitung einer möglichen Phase-III-StudieZeno-BLA...
Merus annonce ses résultats financiers pour le premier trimestre 2024 et fait le point sur ses activités
May 10, 2024 12:36 ET
|
Merus N.V.
Données cliniques intermédiaires initiales concernant le pétosemtamab en association avec le pembrolizumab en traitement de 1re ligne du CETC présentées lors du congrès annuel de l’ASCO 2024 ;...
Codere Online to Release Financial Results for the First Quarter 2024 on May 15
May 10, 2024 12:02 ET
|
Codere Online Luxembourg, S.A.
Madrid, Spain and Tel Aviv, Israel, May 10, 2024 (GLOBE NEWSWIRE) – Codere Online Luxembourg, S.A. (Nasdaq: CDRO / CDROW) (the “Company” or “Codere Online”) a leading online gaming operator in Spain...
Nordic Fibreboard AS 2024. aasta I kvartali auditeerimata majandustulemused
May 10, 2024 10:01 ET
|
Nordic Fibreboard AS
JUHTKONNA ARUANNE Nordic Fibreboard AS konsolideeritud müügitulu oli 2024. aasta 1. kvartalis 1,97 miljonit eurot, mis oli 24% langust võrreldes eelmise aasta sama perioodiga (2023. aasta...
Unaudited financial report of Nordic Fibreboard AS for the first quarter of 2024
May 10, 2024 10:01 ET
|
Nordic Fibreboard AS
Management report Consolidated net sales for Q1 2024 were € 1.97 million, which was a 24% decrease compared to the same period last year (Q1 2023: € 2.60 million). The main business...